Published in Prog Med Virol on January 01, 1974
Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus: clearance of virus in vivo. J Virol (1984) 5.57
Comparative pathology of Lassa virus infection in monkeys, guinea-pigs, and Mastomys natalensis. Bull World Health Organ (1975) 1.83
Functional heterogeneity of lymphocytic choriomeningitis virus-specfic T lymphocytes. I. Identification of effector amd memory subsets. J Exp Med (1975) 1.37
H-2 compatibility requirement for virus-specific T-cell-mediated cytolysis. Evaluation of the role of H-2I region and non-H-2 genes in regulating immune response. J Exp Med (1976) 1.30
Cross-protection against lymphocytic choriomeningitis virus mediated by a CD4+ T-cell clone specific for an envelope glycoprotein epitope of Lassa virus. J Virol (1993) 1.06
Immune responses to LCM virus infection in vivo and in vitro. Mechanisms of immune-mediated disease. Bull World Health Organ (1975) 0.97
Evidence for cytotoxic T-lymphocyte-target cell interaction in brains of mice infected intracerebrally with lymphocytic choriomeningitis virus. Acta Neuropathol (1983) 0.91
Lymphocytic choriomeningitis virus infection in fetal, newborn, and young adult Syrian hamsters (Mesocricetus auratus). Infect Immun (1976) 0.90
The ultrastructure of early visna lesions. Acta Neuropathol (1977) 0.85
Priming of virus-immune memory T cells in newborn mice. Infect Immun (1984) 0.79
Ia antigens in serum during different murine infections. Infect Immun (1979) 0.78
Directions for future research on the pathogenesis of arenaviral infections. Bull World Health Organ (1975) 0.75
An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1. J Virol (1992) 4.85
Requirement for theta-bearing cells in lymphocytic choriomeningitis virus-induced central nervous system disease. Nature (1972) 4.08
Immunopathogenesis of acute central nervous system disease produced by lymphocytic choriomeningitis virus. II. Adoptive immunization of virus carriers. J Exp Med (1972) 2.68
Non-neutralizing monoclonal antibodies can prevent lethal alphavirus encephalitis. Nature (1982) 2.64
Seasonality and the requirements for perpetuation and eradication of viruses in populations. Am J Epidemiol (1979) 2.58
Effect of 2',3'-didehydro-3'-deoxythymidine in an in vitro hollow-fiber pharmacodynamic model system correlates with results of dose-ranging clinical studies. Antimicrob Agents Chemother (1994) 2.46
Immunopathogenesis of acute central nervous system disease produced by lymphocytic choriomeningitis virus. I. Cyclophosphamide-mediated induction by the virus-carrier state in adult mice. J Exp Med (1972) 2.37
Potentiation of experimental arbovirus encephalitis by immunosuppressive doses of cyclophosphamide. Nature (1968) 2.16
Induction or prevention of immunopathological disease by cloned cytotoxic T cell lines specific for lymphocytic choriomeningitis virus. Eur J Immunol (1986) 2.06
The genetics of susceptibility to multiple sclerosis. Epidemiol Rev (1982) 2.00
Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gp120 receptor. Proc Natl Acad Sci U S A (1993) 1.96
Pathogenesis of visna. I. Sequential virologic, serologic, and pathologic studies. Lab Invest (1976) 1.96
The epidemiology of poliomyelitis: enigmas surrounding its appearance, epidemicity, and disappearance. Am J Epidemiol (1979) 1.87
Protective monoclonal antibodies define maturational and pH-dependent antigenic changes in Sindbis virus E1 glycoprotein. Virology (1983) 1.86
Immunosuppression and experimental virus infection of the nervous system. Adv Virus Res (1970) 1.79
Human exposure to SV40: review and comment. Am J Epidemiol (1976) 1.77
Lymphocytic choriomeningitis virus: pathogenesis of acute central nervous system disease. Fed Proc (1972) 1.66
Macrophage-tropic strains of human immunodeficiency virus type 1 utilize the CD4 receptor. J Virol (1990) 1.65
Fatal Japanese encephalitis virus infection in immunosuppresed spider monkeys. Clin Exp Immunol (1970) 1.61
The effect of soft cervical collars on persistent neck pain in patients with whiplash injury. Acad Emerg Med (1996) 1.61
Hepatitis B infection in households of chronic carriers of hepatitis B surface antigen: factors associated with prevalence of infection. Am J Epidemiol (1982) 1.60
Cyclophosphamide-potentiated West Nile viral encephalitis: relative influence of cellular and humoral factors. J Infect Dis (1974) 1.51
Mechanisms of bunyavirus virulence. Comparative pathogenesis of a virulent strain of La Crosse and an avirulent strain of Tahyna virus. Lab Invest (1984) 1.44
Experimental infection of monkeys with Langat virus II. Turnover of circulating virus, 1967. Rev Med Virol (2000) 1.42
Pathogenesis of visna. II. Effect of immunosuppression upon early central nervous system lesions. Lab Invest (1976) 1.42
Eradication of poliomyelitis in the United States. Rev Infect Dis (1983) 1.42
Functional heterogeneity of lymphocytic choriomeningitis virus-specfic T lymphocytes. I. Identification of effector amd memory subsets. J Exp Med (1975) 1.37
Antibody-selected variation and reversion in Sindbis virus neutralization epitopes. J Virol (1986) 1.35
Experimental encephalitis following peripheral inoculation of West Nile virus in mice of different ages. J Hyg (Lond) (1970) 1.34
Pathogenesis of West Nile Virus encepahlitis in mice and rats. II. Virus multiplication, evolution of immunofluorescence, and development of histological lesions in the brain. Am J Epidemiol (1967) 1.31
An epidemiologic and clinical evaluation of Guillain-Barré syndrome reported in association with the administration of swine influenza vaccines. Am J Epidemiol (1984) 1.30
Pathogenesis of West Nile Virus encephalitis in mice and rats. 1. Influence of age and species on mortality and infection. Am J Epidemiol (1967) 1.28
Pathogenesis of type 1 dengue virus infection in suckling, weanling and adult mice. 1. The relation of virus replication to interferon and antibody formation. Am J Epidemiol (1969) 1.28
Organization of the middle RNA segment of snowshoe hare Bunyavirus. Virology (1988) 1.26
Human immunodeficiency virus type 1 causes productive infection of macrophages in primary placental cell cultures. J Infect Dis (1994) 1.24
Histological studies of the monkey neurovirulence of group B arboviruses. I. A semiquantitative grading scale. Am J Epidemiol (1965) 1.24
Characterization of monoclonal antibodies against the G1 and N proteins of LaCrosse and Tahyna, two California serogroup bunyaviruses. Virology (1982) 1.23
Pathogenesis of cerebellar hypoplasia produced by lymphocytic choriomeningitis virus infection of neonatal rats. 1. Evolution of disease following infection at 4 days of age. J Neuropathol Exp Neurol (1973) 1.21
Abrogation of genetically controlled resistance of mice to Treponema pallidum by irradiation. Nature (1980) 1.21
Lymphocytic choriomeningitis virus-induced immunosuppression: a virus-induced macrophage defect. J Immunol (1976) 1.20
The role of antibody in recovery from experimental rabies. I. Effect of depletion of B and T cells. J Immunol (1978) 1.19
Acute rabies death mediated by antibody. Nature (1981) 1.17
Completion of the La Crosse virus genome sequence and genetic comparisons of the L proteins of the Bunyaviridae. Virology (1995) 1.16
Expression of the La Crosse M segment proteins in a recombinant vaccinia expression system mediates pH-dependent cellular fusion. Virology (1993) 1.13
Protection from La Crosse virus encephalitis with recombinant glycoproteins: role of neutralizing anti-G1 antibodies. J Virol (1995) 1.13
An avirulent G1 glycoprotein variant of La Crosse bunyavirus with defective fusion function. J Virol (1985) 1.12
Heterotopic cerebellar granule cells following administration of cyclophosphamide to suckling rats. Brain Res (1969) 1.11
Inhibition by cyclosporin A of rodent malaria in vivo and human malaria in vitro. Infect Immun (1982) 1.10
In vitro inhibition of HIV-1 infectivity by human salivas. AIDS Res Hum Retroviruses (1990) 1.09
Cerebellar hypoplasia in neonatal rats caused by lymphocytic choriomeningitis virus. Science (1971) 1.09
Immunosuppression: a means to assess the role of the immune response in acute virus infections. Fed Proc (1972) 1.09
Molecular determinants of the virulence and infectivity of California serogroup bunyaviruses. Annu Rev Microbiol (1993) 1.08
Antigenic drift in visna: virus variation during long-term infection of Icelandic sheep. J Gen Virol (1983) 1.07
Cross-protection against lymphocytic choriomeningitis virus mediated by a CD4+ T-cell clone specific for an envelope glycoprotein epitope of Lassa virus. J Virol (1993) 1.06
Experimental visna in Icelandic sheep: the prototype lentiviral infection. Rev Infect Dis (1985) 1.06
Major histocompatibility complex class II-associated peptides control the presentation of bacterial superantigens to T cells. J Exp Med (1996) 1.04
Neuroattenuation of an avirulent bunyavirus variant maps to the L RNA segment. J Virol (1991) 1.03
Virulence of La Crosse virus is under polygenic control. J Virol (1986) 1.02
Histological studies of the monkey neurovirulence of group B arboviruses. II. Selection of indicator centers. Am J Epidemiol (1966) 1.02
A G1 glycoprotein epitope of La Crosse virus: a determinant of infection of Aedes triseriatus. Science (1987) 1.02
The Cutter incident. Poliomyelitis following formaldehyde-inactivated poliovirus vaccination in the United States during the Spring of 1955. II. Relationship of poliomyelitis to Cutter vaccine. 1963. Am J Epidemiol (1995) 1.02
The large viral RNA segment of California serogroup bunyaviruses encodes the large viral protein. J Gen Virol (1989) 1.01
Effect of antilymphocyte serium on tacaribe virus infection in infant mice. Infect Immun (1971) 1.01
Epidemiology of multiple sclerosis: critique of the evidence for a viral etiology. Am J Epidemiol (1978) 1.00
Allogeneic H-2 antigen expression is insufficient for tumor rejection. Proc Natl Acad Sci U S A (1987) 1.00
Histological studies of the monkey neurovirulence of group B arboviruses. IV. Evaluation of an attenuated strain (E5) of Langat virus. Am J Epidemiol (1968) 0.98
Polygenic control of neuroinvasiveness in California serogroup bunyaviruses. J Virol (1993) 0.98
Immune responses to LCM virus infection in vivo and in vitro. Mechanisms of immune-mediated disease. Bull World Health Organ (1975) 0.97
Viral hemorrhagic encephalopathy of rats. II. Pathogenesis of central nervous system lesions. Am J Epidemiol (1970) 0.96
Tropism of bunyaviruses: evidence for a G1 glycoprotein-mediated entry pathway common to the California serogroup. Virology (1995) 0.96
Mechanisms of hemopoietic and immunological dysfunction induced by lymphocytic choriomeningitis virus. Infect Immun (1978) 0.95
Precipitating antibodies in experimental visna and natural progressive pneumonia of sheep. Res Vet Sci (1985) 0.95
Pathogenesis of visna. III. Immune responses to central nervous system antigens in experimental allergic encephalomyelitis and visna. Lab Invest (1976) 0.95
Enteric transmission of parvoviruses: pathogenesis of rat virus infection in adult rats. Am J Epidemiol (1972) 0.94
Neuron-specific enolase as an immunocytochemical marker for the diffuse neuroendocrine system in human fetal lung. J Histochem Cytochem (1981) 0.93
Muscarinic acetylcholine receptor regulation by accelerated rate of receptor loss. Biochem Biophys Res Commun (1979) 0.93
Modifications by sodium auro-thio-malate of the expression of virulence in mice by defined strains of Semliki Forest virus. J Gen Virol (1974) 0.92
Reassortment of La Crosse and Tahyna bunyaviruses in Aedes triseriatus mosquitoes. Virus Res (1991) 0.92
Histological studies of the monkey neurovirulence of group B arboviruses. 3. Relative virulence of selected viruses. Am J Epidemiol (1967) 0.92
Virus-specific CD8+ T-cell responses in mice transgenic for a T-cell receptor beta chain selected at random. J Virol (1994) 0.92
B-lymphocyte mediated cytolysis: a complement independent phenomenon. Immunol Commun (1972) 0.92
Recovery from experimental rabies by adoptive transfer of immune cells. J Gen Virol (1981) 0.92
La Crosse bunyavirus can mediate pH-dependent fusion from without. Virology (1984) 0.91
Neuroattenuated bunyavirus variant: derivation, characterization, and revertant clones. J Virol (1990) 0.91
Tumor-specific immunity can be enhanced by transfection of tumor cells with syngeneic MHC-class-II genes or allogeneic MHC-class-I genes. Int J Cancer Suppl (1991) 0.90